Related references
Note: Only part of the references are listed.Integrated genomic analyses identify high-risk factors and actionable targets in T-cell acute lymphoblastic leukemia
Haichuan Zhu et al.
BLOOD SCIENCE (2022)
Integrated genomic analyses identify high-risk factors and actionable targets in T-cell acute lymphoblastic leukemia
Haichuan Zhu et al.
BLOOD SCIENCE (2022)
CAR T cells targeting CD99 as an approach to eradicate T-cell acute lymphoblastic leukemia without normal blood cells toxicity
Jiangzhou Shi et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Hypoxia favors chemoresistance in T-ALL through an HIF1α-mediated mTORC1 inhibition loop
Lucine Fahy et al.
BLOOD ADVANCES (2021)
Integrative pan cancer analysis reveals epigenomic variation in cancer type and cell specific chromatin domains
Lijin K. Gopi et al.
NATURE COMMUNICATIONS (2021)
Overcoming Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: Repurposed Drugs Can Improve the Protocol
Miguel Olivas-Aguirre et al.
FRONTIERS IN ONCOLOGY (2021)
MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance
Jordy C. G. van der Zwet et al.
LEUKEMIA (2021)
3D genome alterations associated with dysregulated HOXA13 expression in high-risk T-lineage acute lymphoblastic leukemia
Lu Yang et al.
NATURE COMMUNICATIONS (2021)
Loss of glucocorticoid receptor expression mediates in vivo dexamethasone resistance in T-cell acute lymphoblastic leukemia
Anica M. Wandler et al.
LEUKEMIA (2020)
High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model
Rebecca A. Luchtel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Reversal of glucocorticoid resistance in paediatric acute lymphoblastic leukaemia is dependent on restoring BIM expression
Cara E. Toscan et al.
BRITISH JOURNAL OF CANCER (2020)
Ribociclib, a Cdk4/Cdk6 kinase inhibitor, enhances glucocorticoid sensitivity in B-acute lymphoblastic leukemia (B-All)
Roberta Bortolozzi et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Dexamethasone in hyperleukocytic acute myeloid leukemia
Sarah Bertoli et al.
HAEMATOLOGICA (2018)
Dexamethasone in hyperleukocytic acute myeloid leukemia
Sarah Bertoli et al.
HAEMATOLOGICA (2018)
The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment
F. Fan et al.
LEUKEMIA (2017)
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
Yu Liu et al.
NATURE GENETICS (2017)
Modulation of Glucocorticoid Resistance in Pediatric T-cell Acute Lymphoblastic Leukemia by Increasing BIM Expression with the PI3K/mTOR Inhibitor BEZ235
Connor P. Hall et al.
CLINICAL CANCER RESEARCH (2016)
deepTools2: a next generation web server for deep-sequencing data analysis
Fidel Ramirez et al.
NUCLEIC ACIDS RESEARCH (2016)
The genetics and mechanisms of T cell acute lymphoblastic leukaemia
Laura Belver et al.
NATURE REVIEWS CANCER (2016)
Acute Lymphoblastic Leukemia in Children
Stephen P. Hunger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
PI3K inhibition synergizes with glucocorticoids but antagonizes with methotrexate in T-cell acute lymphoblastic leukemia
Andre Bortolini Silveira et al.
ONCOTARGET (2015)
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Yang Liao et al.
BIOINFORMATICS (2014)
Bioenergetic modulation overcomes glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia
Amy L. Samuels et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
The Role of Hypoxia and Exploitation of the Hypoxic Environment in Hematologic Malignancies
Barbara Muz et al.
MOLECULAR CANCER RESEARCH (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Direct Reversal of Glucocorticoid Resistance by AKT Inhibition in Acute Lymphoblastic Leukemia
Erich Piovan et al.
CANCER CELL (2013)
Toward a NOTCH1/FBXW7/RAS/PTEN-Based Oncogenetic Risk Classification of Adult T-Cell Acute Lymphoblastic Leukemia: A Group for Research in Adult Acute Lymphoblastic Leukemia Study
Amelie Trinquand et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Fast gapped-read alignment with Bowtie 2
Ben Langmead et al.
NATURE METHODS (2012)
Glucocorticoid-mediated BIM induction and apoptosis are regulated by Runx2 and c-Jun in leukemia cells
N. Heidari et al.
CELL DEATH & DISEASE (2012)
Integrated Transcript and Genome Analyses Reveal NKX2-1 and MEF2C as Potential Oncogenes in T Cell Acute Lymphoblastic Leukemia
Irene Homminga et al.
CANCER CELL (2011)
Targeting HIF1α Eliminates Cancer Stem Cells in Hematological Malignancies
Yin Wang et al.
CELL STEM CELL (2011)
Integrative genomics viewer
James T. Robinson et al.
NATURE BIOTECHNOLOGY (2011)
Rapamycin sensitizes T-ALL cells to dexamethasone-induced apoptosis
Ling Gu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism
A. H. Beesley et al.
BRITISH JOURNAL OF CANCER (2009)
Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance
Guo Wei et al.
CANCER CELL (2006)
Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia
GJL Kaspers et al.
EUROPEAN JOURNAL OF CANCER (2005)
Mechanisms of disease: Acute lymphoblastic leukemia
C Pui et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases
GL Johnson et al.
SCIENCE (2002)
Share Paper
